br55
Halo 3 is a 2007 first-person shooter video game developed by Bungie for the Xbox 360 console. The third installment in the Halo franchise following Halo: Combat Evolved (2001) and Halo 2 (2004), the game's story centers on the interstellar war between 26th-century humanity, a collection of alien races known as the Covenant, and the alien parasite known as the Flood. The player assumes the role of the Master Chief, a cybernetically enhanced supersoldier, as he battles the Covenant and the Flood. In cooperative play, other human players assume the role of allied alien soldiers. The game features vehicles, weapons, and gameplay elements familiar and new to the series, as well as the addition of saved gameplay films, file sharing, and the Forge map editor—a utility which allows the player to perform modifications to multiplayer levels. — Wikipedia
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Earliest trial started Jul 1, 2010 (NCT01253213)
Timeline
Indications
Mechanism of action
- Vascular endothelial growth factor receptor 2BINDING AGENT
KDR binding agent
- Unspecified targetContrast agent
contrast agent
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04248153 | Phase 2 | Oct 14, 2019 | Bracco, National Institutes of Health (NIH) |
| NCT03493464 | Phase 2 | Sep 15, 2018 | Bracco, National Institutes of Health (NIH) |
| NCT03486327 | Phase 2 | Jul 19, 2018 | Bracco, National Institutes of Health (NIH) |
| NCT02142608 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2014 | Bracco, Stanford University |
| NCT01253213 | Early Phase 1 (Phase 1) | Jul 1, 2010 | Bracco, University of Amsterdam |
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bracco | For profit | 5 | 5 | 2 | 2010 |
| National Institutes of Health (NIH) | Government | 3 | 0 | 1 | 2018 |
| Stanford University | Academic/Hospital | 1 | 0 | 1 | 2014 |
| University of Amsterdam | Academic/Hospital | 1 | 0 | 1 | 2010 |